The bill amends section 381.986 of the Florida Statutes to expand the eligibility for medical marijuana use to patients prescribed certain opioid drugs classified as Schedule II controlled substances. It mandates that qualified physicians conduct either an in-person or telehealth examination before issuing or renewing a certification for medical marijuana. Additionally, physicians are required to submit documentation to the appropriate medical boards for patients prescribed opioids, and the bill revises the supply limits for marijuana prescriptions, increasing the maximum allowable amounts. The frequency of patient evaluations for certification renewals is also extended from 30 weeks to 104 weeks.

Furthermore, the bill changes the renewal period for medical marijuana use registry identification cards from annually to biennially and establishes processes for issuing these cards to nonresidents enrolled in other jurisdictions' medical cannabis programs. It also includes provisions to waive fees for honorably discharged veterans and requires the Department of Health to allocate a portion of the fees collected to educate minority communities about medical marijuana. The bill is set to take effect on July 1, 2026.